Product Reports Resources Pricing Login Book a demo

Pivot Bio

Food · Minnetonka, United States · Founded 2011

Pivot Bio is a pioneering startup that addresses the urgent need for sustainable agricultural practices by offering an innovative alternative to synthetic nitrogen fertilizers. The company operates primarily in the agricultural sector, serving farmers across most of the United States. Pivot Bio's core product is a groundbreaking crop nutrition tool that uses naturally occurring microbes to fix nitrogen in cereal crops like corn. This process, known as biological nitrogen fixation, involves converting nitrogen from the air into a form that plants can use, eliminating the need for synthetic fertilizers. The company's business model revolves around selling its microbial nitrogen-fixing products directly to farmers. These products are applied in the field, adhering to the roots of the crops and providing a steady supply of nitrogen throughout the growing season. This method not only enhances crop yields but also mitigates the environmental issues associated with traditional fertilizers, such as leaching, volatilization, and denitrification. Pivot Bio leverages advanced technologies like machine learning and computational modeling to optimize the performance of its microbial solutions. By continuously improving its products, the company aims to offer farmers more efficient and sustainable ways to meet their crops' nitrogen needs. Revenue is generated through the sale of these microbial products, which are available as in-furrow applications and soon as seed treatments. The company is also expanding its product pipeline to include more options for different types of crops and farming practices. In summary, Pivot Bio is transforming agriculture by providing a sustainable, science-based solution to nitrogen fixation, helping farmers increase yields while reducing environmental impact. Keywords: sustainable agriculture, nitrogen fixation, microbial solutions, crop nutrition, synthetic fertilizer alternative, environmental impact, machine learning, computational modeling, cereal crops, U.S. farmers.

Valuation $1–2.5B
Revenue $100–500M
Headcount 100–500
Total funding $500M–1B
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Pivot Bio and the history behind them.

Investors

22 investors on Pivot Bio's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 4 investors entered at this stage
Bill & Melinda Gates Foundation
DCVC
Monsanto
US National Science Foundation
Series A 3 investors entered at this stage
Jenny Rooke
OS Fund
Breakthrough Energy Ventures
Series B+ 15 investors entered at this stage
Temasek
Tekfen Ventures
Spruce Capital Partners
Bunge
Alan Cohen
Continental Grain
Pavilion Capital Partners
Prelude Ventures
Codon Capital
Roger Underwood
Rockefeller Asset Management
Bunge Ventures
Generation Investment Management
G2 Venture Partners
Pavilion Capital

Global footprint

Where Pivot Bio has talent and traffic

Workforce by country
5 countries with
team presence
🇺🇸 United States94%
🇧🇷 Brazil3.7%
🇮🇳 India0.7%
🇬🇧 United Kingdom0.4%
🇨🇦 Canada0.4%
5 countries shown
Web traffic by country
17K monthly visits
across markets
🇺🇸 United States65.3%
🇬🇧 United Kingdom22.4%
🇮🇳 India8.2%
🇨🇦 Canada1.2%
🇦🇺 Australia1.2%
Top 5 markets shown

Talent graph

The shape of Pivot Bio's talent

Dealroom maps Pivot Bio's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

5 standout operatorsDealroom-flagged across the org
11 AI specialistsincl. 1 core researchers
301 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Pivot Bio's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$19M patent portfolio · 30 active families

Estimated portfolio value
$19M
0.93% of valuation · 2.4× larger than top peer JUST ($8M)
30 active patent families
Where Pivot Bio innovates Bacterial strainBiotechnologyBotanyCropEngineered genetic

Where Pivot Bio concentrates vs peers

Each axis is a top-10 topic across Pivot Bio and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Pivot Bio

An AI-synthesized read of the highest-engagement posts about Pivot Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Pivot Bio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.